Giménez-Xavier P - Search Results

1

Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines.

Francisco R, Pérez-Tomás R, Gimènez-Bonafé P, Soto-Cerrato V, Giménez-Xavier P, Ambrosio S. Francisco R, et al. Eur J Pharmacol. 2007 Oct 31;572(2-3):111-9. doi: 10.1016/j.ejphar.2007.06.054. Epub 2007 Jul 4. Eur J Pharmacol. 2007. PMID: 17678643

2

Dopamine induces TNFalpha and TNF-R1 expression in SH-SY5Y human neuroblastoma cells.

Gómez-Santos C, Francisco R, Giménez-Xavier P, Ambrosio S. Gómez-Santos C, et al. Neuroreport. 2007 Oct 29;18(16):1725-8. doi: 10.1097/WNR.0b013e3282f0d3db. Neuroreport. 2007. PMID: 17921876

3

The decrease of NAD(P)H has a prominent role in dopamine toxicity.

Giménez-Xavier P, Gómez-Santos C, Castaño E, Francisco R, Boada J, Unzeta M, Sanz E, Ambrosio S. Giménez-Xavier P, et al. Biochim Biophys Acta. 2006 May;1762(5):564-74. doi: 10.1016/j.bbadis.2006.02.003. Epub 2006 Mar 13. Biochim Biophys Acta. 2006. PMID: 16574383 Free article.

4

LC3-I conversion to LC3-II does not necessarily result in complete autophagy.

Giménez-Xavier P, Francisco R, Platini F, Pérez R, Ambrosio S. Giménez-Xavier P, et al. Int J Mol Med. 2008 Dec;22(6):781-5. Int J Mol Med. 2008. PMID: 19020776

5

Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model.

Giménez-Xavier P, Francisco R, Santidrián AF, Gil J, Ambrosio S. Giménez-Xavier P, et al. Neurotoxicology. 2009 Jul;30(4):658-65. doi: 10.1016/j.neuro.2009.04.007. Epub 2009 May 4. Neurotoxicology. 2009. PMID: 19410601

6

Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.

Gómez-Santos C, Barrachina M, Giménez-Xavier P, Dalfó E, Ferrer I, Ambrosio S. Gómez-Santos C, et al. Brain Res Bull. 2005 Feb 15;65(1):87-95. doi: 10.1016/j.brainresbull.2004.11.008. Brain Res Bull. 2005. PMID: 15680548

7

Intranigral dopamine toxicity and alpha-synuclein response in rats.

Gómez-Santos C, Giménez-Xavier P, Ferrer I, Ambrosio S. Gómez-Santos C, et al. Neurochem Res. 2006 Jul;31(7):861-8. doi: 10.1007/s11064-006-9090-2. Epub 2006 Jun 28. Neurochem Res. 2006. PMID: 16804759

8

The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer.

Romero OA, Setien F, John S, Gimenez-Xavier P, Gómez-López G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-Cespedes M. Romero OA, et al. EMBO Mol Med. 2012 Jul;4(7):603-16. doi: 10.1002/emmm.201200236. Epub 2012 Apr 11. EMBO Mol Med. 2012. PMID: 22407764 Free PMC article.

9

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

Pereira C, Gimenez-Xavier P, Pros E, Pajares MJ, Moro M, Gomez A, Navarro A, Condom E, Moran S, Gomez-Lopez G, Graña O, Rubio-Camarillo M, Martinez-Martí A, Yokota J, Carretero J, Galbis JM, Nadal E, Pisano D, Sozzi G, Felip E, Montuenga LM, Roz L, Villanueva A, Sanchez-Cespedes M. Pereira C, et al. Among authors: gimenez xavier p. Clin Cancer Res. 2017 Jun 15;23(12):3203-3213. doi: 10.1158/1078-0432.CCR-16-1946. Epub 2017 Mar 16. Clin Cancer Res. 2017. PMID: 28302866

10

Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells.

Gimenez-Xavier P, Pros E, Bonastre E, Moran S, Aza A, Graña O, Gomez-Lopez G, Derdak S, Dabad M, Esteve-Codina A, Hernandez Mora JR, Salinas-Chaparro D, Esteller M, Pisano D, Sanchez-Cespedes M. Gimenez-Xavier P, et al. Mol Cancer Ther. 2017 Jul;16(7):1366-1376. doi: 10.1158/1535-7163.MCT-17-0104. Epub 2017 Apr 10. Mol Cancer Ther. 2017. PMID: 28396363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page